PHARMALYTE SOLUTIONS LLC has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, Argentina and Australia. Its main competitors in its focus markets pharmaceuticals are ACHELIOS THERAPEUTICS INC, SALMON PHARMA GMBH and RHEIN SIEGFRIED SA DE CV.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Argentina | 1 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | Chile | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Japan | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | Singapore | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Brandon Stephen F | 8 |
#2 | Okerholm Richard A | 7 |
#3 | Legg Thomas J | 7 |
#4 | Thomas J Legg | 4 |
#5 | Richard A Okerholm | 4 |
#6 | Stephen F Brandon | 4 |
#7 | Zhang Feng | 3 |
#8 | Schoenherr Stuart | 3 |
#9 | Brendon Stephen F | 1 |
#10 | Brandon Sthephen F | 1 |
Publication | Filing date | Title |
---|---|---|
JP2017214352A | High load and controlled release magnesium oral dosage form, and method for producing and using the same | |
US2017020920A1 | High-loading, controlled-release magnesium oral dosage forms and methods for making and using same | |
US2013224264A1 | High-loading, controlled-release magnesium oral dosage forms and methods for making and using same |